Reports about problems associated with power morcellation in gynecologic surgery led to safety warnings in November 2014 by the Food and Drug Administration (FDA) and the Joint Commission.
Welcome to OR Manager, your source of information and insight into the clinical and business management of the surgical suite.
This article is only available to OR Manager subscribers. To read this article, and gain access to all OR Manager resources, please log in below:
Explore Subscription Options
Please contact our Customer Service Team if you are unable to log in at [email protected]
Takeaways Many OR managers said they were overdue for a…
Find out more
Many healthcare professionals are aware of single-use device reprocessing and…
ORs rebounding from the financial impact of COVID-19 are looking…